Docoh
Loading...

PRPH ProPhase Labs

ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The Company is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. This includes the development and marketing of dietary supplements under the TK Supplements® brand. The Company is also developing ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") to offer COVID-19 and other Respiratory Pathogen Panel (RPP) Molecular tests. The Company also continues to actively pursue strategic investments and acquisition opportunities for other companies, technologies and products.

Company profile

Ticker
PRPH
Exchange
CEO
Ted William Karkus
Employees
Incorporated
Location
Fiscal year end
Former names
QUIGLEY CORP
SEC CIK
IRS number
232577138

PRPH stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

14 May 21
29 Jul 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 32.73M 32.73M 32.73M 32.73M 32.73M 32.73M
Cash burn (monthly) (positive/no burn) (positive/no burn) (positive/no burn) 5K 2.63M 465.42K
Cash used (since last report) n/a n/a n/a 19.8K 10.42M 1.84M
Cash remaining n/a n/a n/a 32.71M 22.31M 30.88M
Runway (months of cash) n/a n/a n/a 6541.4 8.5 66.4

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
9 Jun 21 Gleckel Louis MD Option Common Stock Grant Aquire A No No 5.28 100,000 528K 100,000
9 Jun 21 Warren Hirsch Option Common Stock Grant Aquire A No No 5.28 50,000 264K 50,000
9 Jun 21 Barr Jason Michael Option Common Stock Grant Aquire A No No 5.28 100,000 528K 100,000
3 Jun 21 Karkus Ted William Common Stock, par value $0.005 Buy Aquire P No No 5.065 33,943 171.92K 2,333,471
7 May 21 Karkus Ted William Common Stock, par value $0.005 Gift Aquire G Yes No 0 60,000 0 100,000
7 May 21 Karkus Ted William Common Stock, par value $0.005 Gift Dispose G No No 0 120,000 0 2,299,528

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

8.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 29 15 +93.3%
Opened positions 17 5 +240.0%
Closed positions 3 3
Increased positions 7 6 +16.7%
Reduced positions 3 2 +50.0%
13F shares
Current Prev Q Change
Total value 9.58M 4.37M +119.5%
Total shares 1.3M 475.63K +172.4%
Total puts 70.6K 0 NEW
Total calls 29K 0 NEW
Total put/call ratio 2.4
Largest owners
Shares Value Change
Renaissance Technologies 290.61K $2.15M +5.7%
Vanguard 129.11K $955K +104.0%
Wedge Capital Management L L P 119.01K $880K NEW
Kamunting Street Capital Management 97.79K $723K NEW
BK Bank Of New York Mellon 91.09K $674K +275.4%
Geode Capital Management 81.08K $599K +204.1%
Acadian Asset Management 61.22K $452K +8645.1%
FNY Investment Advisers 59.4K $439K NEW
Dimensional Fund Advisors 51.12K $378K NEW
Marshall Wace 50.75K $375K NEW
Largest transactions
Shares Bought/sold Change
Wedge Capital Management L L P 119.01K +119.01K NEW
Kamunting Street Capital Management 97.79K +97.79K NEW
BK Bank Of New York Mellon 91.09K +66.82K +275.4%
Vanguard 129.11K +65.81K +104.0%
Acadian Asset Management 61.22K +60.52K +8645.1%
FNY Investment Advisers 59.4K +59.4K NEW
Geode Capital Management 81.08K +54.42K +204.1%
Dimensional Fund Advisors 51.12K +51.12K NEW
Marshall Wace 50.75K +50.75K NEW
Perritt Capital Management 45.17K +45.17K NEW

Financial report summary

?
Management Discussion
  • Net sales for Fiscal 2020 increased $4.6 million to $14.5 million as compared to $9.9 million for Fiscal 2019. The increase in net sales for Fiscal 2020 as compared to Fiscal 2019 is principally due to increased third party customer orders in contract manufacturing and revenue of $1.3 million related to our new diagnostic services business.
  • Cost of sales for Fiscal 2020 were $9.9 million as compared to $7.3 million for Fiscal 2019. We realized a gross profit $4.6 million for Fiscal 2020 as compared to $2.6 million for Fiscal 2019. For Fiscal 2020, our gross margin was 31.8% as compared to 26.5% for Fiscal 2019. Such increase in gross margin for Fiscal 2020 as compared to Fiscal 2019 is principally due to (i) an increase in the absorption of fixed production costs and (ii) fluctuations in our product mix and pricing fluctuations from period to period and increased margins generally associated with the new diagnostic services business. Gross margins have historically been influenced by fluctuations in quarter-to-quarter production volume, fixed production costs and related overhead absorption, raw ingredient costs, inventory mark to market write-downs and timing of shipments to customers.
  • Sales and marketing expense for Fiscal 2020 was $1.3 million as compared to $1.0 million for Fiscal 2019. The increase in sales and marketing expenses of $245,000 was related to an increase in advertising expenses for our retail consumer products and the new diagnostic services business.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: abatement, adulteration, antidilutive, area, assembled, assigned, authoritative, Avenue, beneficial, bifurcated, BRG, certainty, classification, CODM, construction, correlation, corroborated, CPM, culminating, deciding, Decision, deducting, direct, efficacy, embedded, enterprise, estate, exit, feet, fewer, forma, freestanding, Garden, goodwill, gradual, Hedging, hierarchical, host, identical, immaterial, implicit, incremental, indexed, indirect, institutional, instrument, intangible, Kit, labor, Landlord, lessee, lesser, lieu, life, linked, lived, Maker, minimal, nil, NJ, nonrecurring, opening, payer, preliminary, preventative, pro, quantitative, reagent, real, recurring, refusal, registered, remittance, removing, rental, revise, RPG, screening, segment, space, specimen, statement, Stewart, stockholder, stream, Subtopic, targeted, unadjusted, underwriting, unique, viral, wide, workforce, world, York
Removed: acceptable, adequate, agent, alleging, Answer, application, apply, asserting, assessed, August, authority, behalf, breach, Call, cellular, claim, collect, collected, comparability, Complaint, concurrent, consistency, continued, corporation, correction, court, damaged, decrease, Delaware, deposited, depreciated, discontinue, distancing, District, Eastern, enforceable, escrow, evolving, exclude, fraud, governmental, implementation, imposed, improve, indemnification, initially, integrating, interpretation, listing, main, manage, matter, MCH, Meda, mix, negatively, Nevada, notwithstanding, November, operational, owed, past, pattern, pending, phone, plaintiff, positive, positively, protection, realize, reflected, regional, Registry, released, represent, request, residential, resolved, respond, satisfy, seasonality, sending, short, similarly, simplify, Simplifying, single, social, specialty, spread, statute, strength, subscription, sum, survive, telemarketing, telephone, text, travel, twelve, undiscounted, uniform, violated, wrote